Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
745.95
-4.82 (-0.64%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,717,349
Open
749.42
Bid (Size)
742.50 (1)
Ask (Size)
747.36 (5)
Prev. Close
750.77
Today's Range
743.77 - 752.20
52wk Range
367.35 - 800.78
Shares Outstanding
N/A
Dividend Yield
0.61%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
Today 12:50 EDT
Facing a shortage, GLP-1 weight loss drugs by Eli Lilly & Novo Nordisk struggle to meet demand. Learn about supply issues and efforts to address them, impacting availability till 2025.
Via
Benzinga
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
Today 10:33 EDT
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Via
Investor's Business Daily
Performance
YTD
+25.96%
+25.96%
1 Month
-3.47%
-3.47%
3 Month
+19.67%
+19.67%
6 Month
+26.26%
+26.26%
1 Year
+101.35%
+101.35%
More News
Read More
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years
Today 10:30 EDT
Via
Benzinga
Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.
Today 10:23 EDT
Via
InvestorPlace
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
Today 6:02 EDT
Via
AB Newswire
Topics
Economy
Exposures
Interest Rates
Eli Lilly and Co's Options Frenzy: What You Need to Know
April 17, 2024
Via
Benzinga
2 Growth Stocks That Turned $10,000 Into More Than $100,000 in Just 10 Years
Today 5:10 EDT
Via
The Motley Fool
Top Research Reports For Eli Lilly, Linde & Caterpillar
April 17, 2024
Via
Talk Markets
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
April 17, 2024
Via
The Motley Fool
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
April 17, 2024
Via
Investor's Business Daily
Nasdaq 100 Forecast: QQQ Inches Higher Ahead Of Fed Speakers
April 17, 2024
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Eli Lilly's Famed Weight Loss Drug Zepbound Works As Sleep Apnea Treatment, Successful Late-Stage Studies Show
April 17, 2024
Via
Benzinga
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
April 17, 2024
Via
InvestorPlace
Topics
ETFs
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
April 16, 2024
Via
Benzinga
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
April 16, 2024
Via
InvestorPlace
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
April 16, 2024
Via
Talk Markets
BTIG Research Predicts Over 118% Rally for These 3 Stocks
April 15, 2024
Via
InvestorPlace
Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF?
April 15, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Better Growth Play: Merck or The Vanguard Growth Index Fund?
April 15, 2024
Via
The Motley Fool
Novo Nordisk Arms Wegovy to Be a Triple Threat
April 15, 2024
Via
MarketBeat
3 Magnificent Stocks That Could Double or More by 2030
April 13, 2024
Via
The Motley Fool
This Vanguard ETF Has Skyrocketed 40% in 12 Months. Is It a No-Brainer Buy Right Now?
April 13, 2024
Via
The Motley Fool
Topics
ETFs
Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week
April 12, 2024
Via
The Motley Fool
Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating
April 12, 2024
Via
Benzinga
Eli Lilly Suffers Legal Loss For Its Popular Weight Loss/Diabetes Drug In Lawsuit Against Florida Compounding Pharmacy
April 12, 2024
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.